Oruka Therapeutics (ORKA) Stock Chart & Stock Price History $14.30 +0.70 (+5.15%) Closing price 08/4/2025 04:00 PM EasternExtended Trading$14.36 +0.06 (+0.42%) As of 08/4/2025 07:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Oruka Therapeutics Stock Price Performance The Oruka Therapeutics (ORKA) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock decreased 26.25%. In the past month, the stock has increased 13.54%, reflecting recent market activity. As of the latest close, Oruka Therapeutics traded at $14.30 with a market cap of $535.41 million and volume of 93,299 shares. Receive ORKA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oruka Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+5.22%1 Month Performance+13.54%3 Month Performance+43.29%Year-To-Date Performance-26.25% ORKA Stock Chart for Tuesday, August, 5, 2025 ORKA Chart by TradingView Oruka Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/04/2025$13.60$14.30+5.15%$14.45$13.5293,299 shs$535.41 million08/01/2025$13.59$13.60+0.07%$13.92$13.02142,850 shs$509.18 million07/31/2025$13.79$13.59-1.45%$14.07$13.42111,019 shs$508.82 million07/30/2025$13.73$13.79+0.44%$14.32$13.51118,282 shs$516.30 million07/29/2025$14.01$13.73-2.00%$14.37$13.58100,657 shs$514.05 million07/28/2025$14.25$14.01-1.68%$14.46$13.8688,745 shs$524.55 million07/25/2025$14.23$14.25+0.14%$14.35$13.7070,223 shs$533.53 million07/24/2025$14.54$14.23-2.13%$14.56$14.0369,615 shs$532.77 million07/23/2025$14.06$14.54+3.41%$14.63$14.0899,325 shs$544.38 million07/22/2025$13.77$14.06+2.11%$14.13$13.51124,073 shs$526.42 million Get the Latest News and Ratings for ORKA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oruka Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/21/2025$14.54$13.77-5.30%$15.61$13.43236,288 shs$515.55 million07/18/2025$15.36$14.54-5.34%$15.70$14.16389,758 shs$544.38 million07/17/2025$14.80$15.36+3.78%$15.58$14.69222,212 shs$575.08 million07/16/2025$14.25$14.80+3.86%$14.85$14.03100,129 shs$554.13 million07/15/2025$14.70$14.25-3.06%$15.12$14.10126,918 shs$533.52 million07/14/2025$14.23$14.70+3.30%$14.84$14.01117,126 shs$550.37 million07/11/2025$14.07$14.23+1.14%$14.37$13.9391,928 shs$532.77 million07/10/2025$14.23$14.07-1.12%$14.94$13.83220,187 shs$526.78 million07/09/2025$13.39$14.23+6.27%$14.78$13.39269,587 shs$532.77 million07/08/2025$13.29$13.39+0.75%$13.76$13.15219,758 shs$501.32 million07/07/2025$12.60$13.29+5.52%$13.67$12.48406,752 shs$497.58 million07/04/2025$12.60$12.60$12.93$12.10148,945 shs$471.56 million Related Companies IRON Stock Chart MESO Stock Chart CNTA Stock Chart VCEL Stock Chart CGON Stock Chart DNLI Stock Chart BLTE Stock Chart OCUL Stock Chart KNSA Stock Chart APGE Stock Chart Receive ORKA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oruka Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ORKA) was last updated on 8/5/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oruka Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oruka Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
